Biotech and Pharma's March Shake-Up: Layoffs Signal Industry Evolution
Singapore, April 1 -- March 2024 has been marked by a series of layoffs in the biotech and pharmaceutical sector, raising concerns and drawing attention to the dynamics within these industries. From Moderna's resizing of its COVID-19 footprint to GSK's parting ways with Bellus Health employees, the landscape appears to be shifting. These layoffs, although reflecting strategic decisions by individual companies, collectively paint a broader picture of the challenges and transformations underway in the biotech and pharma domain.
However, collectively, they paint a broader picture of the challenges and transformations underway in the biotech and pharma domain.
Moderna's Strategic Adaptation: Moderna's decision to downsize its manufacturing ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.